menu search

Celularity announces phase 1 data showing that mlasc therapy in patients with crohn’s disease may be a therapeutic option to manage inflammatory bowel diseases and prevent fistula formation

Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derive...

May 19, 2023, 8:21 pm


Search within

Pages Search Results: